5. It's unclear from the news story if Bangladesh's approval of Bexovid (the generic version of Paxlovid) is under procedures for patented products within the law, or because the drug's patent is not registered in Bangladesh.
6. The news story says Beximco Pharma may want to sell Bexovid outside Bangladesh
Marketing elsewhere? Either a country where the drug doesn't have a registered patent, or by compulsory licence, or a patent waiver (still controversial in the WTO)
This is an attempt to explain plurilaterals. It’s in 2 parts:
• General explanation, including political and legal pitfalls
• The plurilaterals, each in a nutshell. There are 17, so I’m afraid it’s long, from e-commerce to environment and trade
There was so much members disagreed about, most of it with little sign of compromise. They couldn’t even agree on what to call the statement to be issued at the end of the Ministerial Conference #MC12
In principle, those commitments would comply with WTO non-discrimination rules (“most-favoured nation”), meaning they would apply to service suppliers from all WTO members, including free-riding non-participants.
Members’ individual commitments are drafted according to a “reference paper” released yesterday.
That reference paper will probably not be legally binding (wait for tomorrow’s announcement), but the “schedules” of commitments will be, when certified
Confirmed, it's an urgent informal meeting of the WTO General Council at 9.30 (in about 14 minutes) to discuss the deteriorating health situation, travel restrctions and possible alternative arrangements for the Ministerial Conference